ENDRA Life Sciences (NDRA) Research Hub

ENDRA Life Sciences (NDRA) trades on NASDAQ, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-09-11, shares last closed at 5.62 USD (-3.60%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.69, market cap 0.00B. This hub links to the full technical, earnings and options research available for NDRA.

Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Diagnostics & Research)
ExchangeNASDAQ, US
Last close5.62 USD (-3.60%)
52-week range4.17 USD – 6.55 USD
Trend regimeRange
14-day RSI66 (Bullish)
Trailing P/E-0.69
Market cap0.00B
Dividend yield0.00%
Next earnings2026-08-13

Available research for NDRA

Earnings

NDRA earnings: next report 2026-08-13, real EPS beat/miss history, analyst consensus Buy, P/E -0.69. Updated 2026-07-23.

Options: Covered Call

Covered Call on NDRA: how it works, illustrative setup around the real 5.62 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on NDRA: how it works, illustrative setup around the real 5.62 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on NDRA: how it works, illustrative setup around the real 5.62 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

NDRA technical analysis: range, last 5.62 USD, RSI 66, 52w range 4.17 USD–6.55 USD, real support/resistance. Updated 2026-09-11.

Frequently asked questions

What sector is NDRA in?

ENDRA Life Sciences (NDRA) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, US.

Is NDRA in an uptrend or downtrend?

As of 2026-09-11, NDRA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is NDRA's trailing P/E ratio?

NDRA's trailing P/E is -0.69, with a market cap of 0.00B. See the earnings research page for full valuation detail.

When does NDRA next report earnings?

NDRA is next scheduled to report earnings on 2026-08-13, with a consensus EPS estimate of -0.84 USD.